Avanos Medical reports Q3 2022 earnings; no specific data provided in filing excerpt

AVANOS MEDICAL, INC.

2022-Q3 EPS reported $0.71 revenue$602,500,000

Quarter ended September 30, 2022 results disclosed on November 2, 2022.
Key financial metrics (revenue, net income, EPS) not available from the supplied text.
Investors should consult the full press release for complete details.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

AVANOS MEDICAL, INC. reported financial results for the three months ended September 30, 2022.

Period: the three months ended September 30, 2022
Result: reported results

Exact text from the filing

Avanos Medical, Inc. (the “Company”) announced its results of operations for the three months ended September 30, 2022 in a press release dated November 2, 2022.

View on SEC.gov

Browse all earnings releases →

AVANOS MEDICAL, INC. filing history →

Source: SEC EDGAR

accession 0001606498-22-000077

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.